menu
    • menu

    Company profile for Orion Biotechnology

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Orion Biotechnology is a clinical stage biopharmaceutical company focused on discovering and developing best-in-class immunotherapeutics based on novel recombinant chemokine analogs. Our goal is to significantly improve the health outcomes of populations affected by serious diseases in the area of oncology, neuroinflammatory disorders, inflammatory bowel disease, HIV, and others. By utilizing our proprietary Drug Discovery ...
    Orion Biotechnology is a clinical stage biopharmaceutical company focused on discovering and developing best-in-class immunotherapeutics based on novel recombinant chemokine analogs. Our goal is to significantly improve the health outcomes of populations affected by serious diseases in the area of oncology, neuroinflammatory disorders, inflammatory bowel disease, HIV, and others. By utilizing our proprietary Drug Discovery Platform we will be able to accelerate the identification and lead optimization of chemokine analogs and other small proteins.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Orion BiotechnologyCanada Flag
    Country
    Country
    Canada
    Address
    Address
    343 Preston Street 11th floor, Ottawa, On K1S 1N4
    Telephone
    Telephone
    +1 343.291.1032
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://orionbiotechnology.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bayer eyes wider Nubeqa use on new prostate cancer trial data
    Bayer eyes wider Nubeqa use on new prostate cancer trial data

    17 Jul 2024

    // Ludwig Burger REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/bayer-says-darolutamide-shown-slow-prostate-cancer-progression-2024-07-17/

    Ludwig Burger REUTERS
    17 Jul 2024
    Share Share
    Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration
    Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration

    12 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220712005402/en

    BUSINESSWIRE
    12 Jul 2022
    Share Share
    Evofem Biosciences, Orion Biotechnology Enter OB-002 Alliance
    Evofem Biosciences, Orion Biotechnology Enter OB-002 Alliance

    20 Dec 2021

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2021-12-20/evofem-biosciences-orion-biotechnology-enter-ob-002-alliance/?widget=listSection

    CONTRACTPHARMA
    20 Dec 2021
    Share Share
    ORION BIOTECHNOLOGY RECEIVES FUNDING TO ADVANCE ITS LEAD GPCR-TARGETED
    ORION BIOTECHNOLOGY RECEIVES FUNDING TO ADVANCE ITS LEAD GPCR-TARGETED

    04 Nov 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/11/04/2327789/0/en/ORION-BIOTECHNOLOGY-RECEIVES-FUNDING-TO-ADVANCE-ITS-LEAD-GPCR-TARGETED-THERAPEUTIC.html

    GLOBENEWSWIRE
    04 Nov 2021
    Share Share
    Orion Successfully Completes Phase 1 Clinical Trial of a First-in-Class
    Orion Successfully Completes Phase 1 Clinical Trial of a First-in-Class

    15 Oct 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/10/15/2109330/0/en/Orion-Biotechnology-Successfully-Completes-Phase-1-Clinical-Trial-of-a-First-in-Class-Precision-Engineered-Ligand-Analog-for-HIV-Prevention.html

    GLOBENEWSWIRE
    15 Oct 2020
    Share Share
    Orion Biotechnology Receives Funding to Test OB-002 for Treatment of COVID-19
    Orion Biotechnology Receives Funding to Test OB-002 for Treatment of COVID-19

    30 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/07/30/2070498/0/en/Orion-Biotechnology-Receives-Funding-to-Test-OB-002-for-Treatment-of-COVID-19.html

    GLOBENEWSWIRE
    30 Jul 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search